Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-cell function and diabetic control in insulin dependent diabetes melletus.

O K Faber

    Acta Endocrinologica. Supplementum
    |January 1, 1985
    PubMed
    Summary

    Insulin-dependent diabetic patients retain some beta-cell function, measurable by C-peptide, even after years of treatment. This residual insulin secretion, however minimal, significantly impacts metabolic control.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Renal threshold for glucose in non-insulin-dependent diabetic patients.

    Diabetes research and clinical practice·1997
    Same author

    The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus.

    Acta endocrinologica·1991
    Same author

    Acute actions of sulfonylurea drugs during long-term treatment of NIDDM.

    Diabetes care·1990
    Same author

    Sulfonylureas. Why, which, and how?

    Diabetes care·1990
    Same author

    Metabolic effect of islet B-cell function in insulin-treated diabetes.

    Scandinavian journal of clinical and laboratory investigation·1989
    Same author

    Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.

    Diabetic medicine : a journal of the British Diabetic Association·1989

    Area of Science:

    • Endocrinology
    • Metabolic Diseases
    • Diabetes Research

    Background:

    • Beta-cell dysfunction is central to insulin-dependent diabetes mellitus.
    • Assessing residual beta-cell function is crucial for understanding disease progression and management.
    • Plasma C-peptide is a reliable biomarker for endogenous insulin production.

    Purpose of the Study:

    • To evaluate the persistence and significance of beta-cell function in insulin-dependent diabetes.
    • To correlate C-peptide levels with disease duration in diabetic patients.

    Main Methods:

    • Plasma C-peptide measurements were used to assess beta-cell function.
    • Patient cohorts were analyzed based on disease duration (early stage vs. >15 years of treatment).

    Main Results:

    • All patients in the initial months of insulin-dependent diabetes exhibited measurable beta-cell function via C-peptide.
    • Approximately 15% of patients with over 15 years of treatment still showed detectable C-peptide levels.
    • Beta-cells demonstrated the ability to adjust insulin secretion based on blood glucose fluctuations.

    Conclusions:

    • Residual beta-cell function is present in a subset of long-standing insulin-dependent diabetic patients.
    • Even minimal insulin secretion has significant metabolic implications.
    • Monitoring C-peptide levels can provide insights into beta-cell preservation and metabolic status in diabetes.

    Related Experiment Videos